ArticleJournal for immunotherapy of cancer2023

Correction: Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.